The pharmacological bases of the antiangiogenic activity of paclitaxel
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The pharmacological bases of the antiangiogenic activity of paclitaxel
Authors
Keywords
Paclitaxel, Antiangiogenic drugs, Angiogenesis, Preclinical studies
Journal
ANGIOGENESIS
Volume 16, Issue 3, Pages 481-492
Publisher
Springer Nature
Online
2013-02-06
DOI
10.1007/s10456-013-9334-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumors That Acquire Resistance to Low-Dose Metronomic Cyclophosphamide Retain Sensitivity to Maximum Tolerated Dose Cyclophosphamide
- (2015) Urban Emmenegger et al. NEOPLASIA
- Inhibition of SIRT2 Potentiates the Anti-motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies
- (2015) Katiuscia Bonezzi et al. NEOPLASIA
- Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
- (2012) Giacomo Allegrini et al. ANGIOGENESIS
- Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma
- (2012) S. J. Lee et al. CLINICAL CANCER RESEARCH
- Paclitaxel in Cancer Treatment: Perspectives and Prospects of its Delivery Challenges
- (2012) Somnath Singh et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity
- (2012) Liang Liang et al. JOURNAL OF CONTROLLED RELEASE
- Age and Comorbidity Considerations Related to Radiotherapy and Chemotherapy Administration
- (2012) George Rodrigues et al. SEMINARS IN RADIATION ONCOLOGY
- Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
- (2011) Yutaka Yamamoto et al. OncoTargets and Therapy
- Antiangiogenic Activity of Sterically Stabilized Liposomes Containing Paclitaxel (SSL-PTX): In Vitro and In Vivo
- (2010) Yue Huang et al. AAPS PHARMSCITECH
- Metronomic Chemotherapy Enhances Antitumor Effects of Cancer Vaccine by Depleting Regulatory T Lymphocytes and Inhibiting Tumor Angiogenesis
- (2010) Chi-An Chen et al. MOLECULAR THERAPY
- Low-dose metronomic chemotherapy of paclitaxel synergizes with cetuximab to suppress human colon cancer xenografts
- (2009) Mu Zhang et al. ANTI-CANCER DRUGS
- Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in Mice
- (2009) Hongchi Jiang et al. CANCER INVESTIGATION
- Antivascular Actions of Microtubule-Binding Drugs
- (2009) E. L. Schwartz CLINICAL CANCER RESEARCH
- Functionalized nanospheres loaded with anti-angiogenic drugs: Cellular uptake and angiosuppressive efficacy
- (2009) Taha Hammady et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells
- (2009) Mariko Muta et al. ONCOLOGY
- Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
- (2009) Qiang Fu et al. Recent Patents on Anti-Cancer Drug Discovery
- Active targeting schemes for nanoparticle systems in cancer therapeutics
- (2008) James D. Byrne et al. ADVANCED DRUG DELIVERY REVIEWS
- A Novel Assay to Assess the Effectiveness of Antiangiogenic Drugs in Human Breast Cancer
- (2008) John M. Lyons et al. ANNALS OF SURGICAL ONCOLOGY
- A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
- (2008) G Allegrini et al. BRITISH JOURNAL OF CANCER
- Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells
- (2008) Emanuela Napoleone et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search